FdaApplication

NDA 020764

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE LLC
application_typeNDA
approval_date1998-08-24

Products (4)

ProductActive ingredientStrengthDosage form
LAMICTAL CDLAMOTRIGINE100MGTABLET, FOR SUSPENSION;ORAL
LAMICTAL CDLAMOTRIGINE5MGTABLET, FOR SUSPENSION;ORAL
LAMICTAL CDLAMOTRIGINE25MGTABLET, FOR SUSPENSION;ORAL
LAMICTAL CDLAMOTRIGINE2MGTABLET, FOR SUSPENSION;ORAL

4 products